Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Royal Marsden NHS Foundation Trust
With
King's College London
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
1. Age \> 18 at randomisation
2. Men with histological confirmation of prostate adenocarcinoma who are receiving or planned to receive ADT with an LHRHa as part of their PCa treatment
3. If already started ADT, have received no more than eight weeks ADT at randomisation
4. Planned for radiotherapy
5. Assessed by clinical team to be safe to exercise and safe to enter the trial with no absolute contraindications to exercise as defined by clinical guidance
6. Able to use technological aspects of the intervention including access to MyMarsden and a device for video conferencing
7. Fluent in English and able to understand instructions
8. WHO performance status 0-2
9. Able to give written informed consent
You may not be if
1. Men planned to receive an androgen receptor-targeted agent (ARTA) or chemotherapy
2. Absolute contraindication to exercise as defined by ACPICR standards. This includes:
* New symptoms of angina
* New or unstable heart failure
* Newly diagnosed diabetes that is not controlled
* New or untreated arrhythmias
* Resting tachycardia or new bradycardia (not linked to changes in medications)
* Symptomatic hypotension
* Uncontrolled hypertension (SBP ≥ 180mmHg or DBP≥ 100mmHg)
3. Unstable spinal bone metastasis or at high risk of a fracture
